Tudor Investment Corp’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-58,640
Closed -$974K 1503
2025
Q1
$974K Sell
58,640
-13,040
-18% -$217K ﹤0.01% 1029
2024
Q4
$1.32M Sell
71,680
-21,724
-23% -$399K 0.01% 903
2024
Q3
$1.44M Sell
93,404
-8,568
-8% -$132K 0.01% 896
2024
Q2
$1.66M Buy
101,972
+26,484
+35% +$430K 0.01% 793
2024
Q1
$1.4M Buy
+75,488
New +$1.4M 0.01% 787
2023
Q4
Sell
-81,503
Closed -$1.7M 1421
2023
Q3
$1.7M Buy
+81,503
New +$1.7M 0.02% 712
2022
Q3
Sell
-84,833
Closed -$1.2M 1537
2022
Q2
$1.2M Buy
+84,833
New +$1.2M 0.03% 725
2022
Q1
Sell
-46,063
Closed -$1.08M 1482
2021
Q4
$1.08M Buy
46,063
+23,580
+105% +$550K 0.02% 846
2021
Q3
$373K Buy
+22,483
New +$373K 0.01% 1237
2021
Q2
Sell
-32,635
Closed -$842K 1449
2021
Q1
$842K Buy
32,635
+28,360
+663% +$732K 0.02% 909
2020
Q4
$229K Buy
+4,275
New +$229K 0.01% 1187
2020
Q3
Sell
-4,264
Closed -$207K 1226
2020
Q2
$207K Buy
+4,264
New +$207K 0.01% 1009
2020
Q1
Sell
-44,793
Closed -$1.92M 1015
2019
Q4
$1.92M Sell
44,793
-90,572
-67% -$3.87M 0.09% 293
2019
Q3
$4.87M Buy
+135,365
New +$4.87M 0.17% 122
2019
Q1
Sell
-63,082
Closed -$1.02M 1066
2018
Q4
$1.02M Buy
+63,082
New +$1.02M 0.02% 374
2018
Q3
Sell
-87,705
Closed -$1.34M 1046
2018
Q2
$1.34M Buy
+87,705
New +$1.34M 0.05% 335
2018
Q1
Sell
-51,869
Closed -$1.56M 955
2017
Q4
$1.56M Buy
+51,869
New +$1.56M 0.04% 226
2017
Q3
Sell
-16,847
Closed -$470K 1047
2017
Q2
$470K Buy
+16,847
New +$470K 0.01% 582
2016
Q1
Sell
-14,405
Closed -$514K 1457
2015
Q4
$514K Sell
14,405
-922
-6% -$32.9K 0.01% 730
2015
Q3
$507K Sell
15,327
-3,642
-19% -$120K 0.02% 721
2015
Q2
$794K Buy
+18,969
New +$794K 0.02% 498
2014
Q4
Sell
-10,748
Closed -$266K 1404
2014
Q3
$266K Buy
+10,748
New +$266K 0.01% 1053